8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2007 / Prospective clinical trial
Researchers evaluated the in vivo effects of daily oral 1-3, 1-6, D-beta glucan given for 15 days to 23 women with advanced breast cancer. Mean monocyte counts increased significantly from 326/mm3 to 496/mm3 (p=0.015). CD14-positive monocyte expression of CD95 rose from 48.17% to 69.23% (p=0.002) and CD45RA expression rose from 49.9% to 61.52% (p=0.001).
Demir G, Klein HO, Mandel-Molinas N, et al. Int Immunopharmacol, 2007. PMID 17161824
2007 / Interventional pilot study (before-and-after)
Ten non-smoking Jordanian volunteers (5 men and 5 women) consumed a standard diet of 500 g of broccoli for 6 days, followed by caffeine testing on day 7 to measure CYP1A2 and CYP2A6 activities via urinary metabolite ratios. Following broccoli consumption, mean CYP1A2 activity significantly increased from 21.1+/-3.2 to 52.5+/-6.6 in men and from 27.6+/-1.6 to 36.6+/-8.4 in women (P<0.005). Mean CYP2A6 activity also significantly increased from 0.061+/-0.040 to 0.193+/-0.02 in men and from 0.144+/-0.039 to 0.214+/-0.064 in women (P<0.05).
Hakooz N, Hamdan I Curr Drug Metab, 2007. PMID 17266520
2007 / Phase I dose escalation pharmacokinetic study
A phase I study evaluated single oral doses of resveratrol (0.5, 1, 2.5, or 5 g) in 10 healthy volunteers per dose level. Administration did not cause serious adverse events. Peak plasma levels of resveratrol at the 5 g dose were 539 +/- 384 ng/mL (2.4 micromol/L), occurring 1.5 hours post-dose, while peak levels of metabolites were 3- to 8-fold higher. The authors note that because in vitro cancer chemopreventive effects require at least 5 micromol/L, high-dose resveratrol might be insufficient to elicit systemic levels commensurate with efficacy, though conjugate metabolites warrant investigation.
Boocock DJ, Faust GE, Patel KR, et al. Cancer Epidemiol Biomarkers Prev, 2007. PMID 17548692
2007 / Randomized controlled trial
Researchers evaluated dietary intakes of total protein and soy isoflavones in relation to the IGF axis in prostate cancer patients participating in the Prostate Cancer Lifestyle Trial, which included a very low-fat vegan diet supplemented with 58 g/day of soy protein versus usual care. After one year, the intervention group reported significantly higher intakes of dietary protein and soy isoflavones than controls (P < 0.001). IGF-1 increased significantly in both groups, while IGFBP-1 rose in the experimental group only (P < 0.01). Increases in vegetable protein over one year were associated with increases in IGFBP-1 among intervention patients (P < 0.05).
Dewell A, Weidner G, Sumner MD, et al. Nutr Cancer, 2007. PMID 17571965
2007 / Randomized controlled trial
In a randomized trial of 3,088 women previously treated for early-stage breast cancer, an intensive telephone-counseling intervention promoted high vegetable, fruit, and fiber intake alongside low dietary fat. Over an average of 7.3 years of follow-up, invasive events occurred in 16.7% of intervention participants versus 16.9% of controls (adjusted HR, 0.96; 95% CI, 0.80-1.14). All-cause mortality was also similar between groups, reaching 10.1% versus 10.3% (adjusted HR, 0.91; 95% CI, 0.72-1.15).
Pierce JP, Natarajan L, Caan BJ, et al. JAMA, 2007. PMID 17635889
2007 / Intervention trial with in vitro experiments
Volunteers were fed a high red meat or a vegetarian diet, and fecal and ileal samples were analyzed for nitrosyl iron, nitrosothiols, and heme, alongside in vitro gastric simulations. Nitrosyl iron and nitrosothiols were significantly increased in ileal and fecal samples following the high red meat diet compared with the vegetarian diet (p < 0.0001). Significantly more nitrosyl iron than nitrosothiols was present in ileal (p < 0.0001) and fecal (p < 0.001) samples. Fecal nitrosyl iron strongly correlated with heme (0.776; p < 0.0001), and ESR confirmed nitrosyl heme in feces after the high red meat diet.
Kuhnle GG, Story GW, Reda T, et al. Free Radic Biol Med, 2007. PMID 17761300
2007 / Intervention study (pre-post with working day control)
Twelve healthy male subjects participated in a 3-day/2-night trip across three forest fields, involving scheduled 2-hour walks, to investigate the effect of forest bathing on immune function. Measurements were compared to a baseline normal working day. Almost all subjects (11/12) showed higher NK activity after the trip (about 50 percent increased). The trip also significantly increased the numbers of NK cells and cells expressing perforin, granulysin, and granzymes A/B.
Li Q, Morimoto K, Nakadai A, et al. Int J Immunopathol Pharmacol, 2007. PMID 17903349
2007 / Intervention trial with animal and human components
Researchers evaluated the protective effects of topical sulforaphane-rich extracts of 3-day-old broccoli sprouts against UV radiation in mice and humans. In six human subjects (three males and three females, 28-53 years of age), the extract up-regulated phase 2 enzymes and achieved a mean reduction in erythema across six UVR doses (300-800 mJ/cm² in 100 mJ/cm² increments) of 37.7% (range 8.37-78.1%; P = 0.025).
Talalay P, Fahey JW, Healy ZR, et al. Proc Natl Acad Sci U S A, 2007. PMID 17956979
2006 / Dietary intervention studies (pooled analysis)
Fecal water samples were collected from 21 individuals across two studies who consumed diets containing varying amounts of red meat, protein, heme, and iron to assess genotoxicity using two Comet assay protocols. Fecal water genotoxicity showed no significant effect from diet (P > 0.20), mean transit time (P = 0.588), or weight (P = 0.705), but had a significant effect of age (P = 0.019). There was no significant correlation between fecal homogenate ATNC concentrations and fecal water genotoxicity (r = 0.04, P = 0.74). ATNC levels were significantly lower in fecal water (272 microg/kg) than in fecal homogenate (895 microg/kg) (P < 0.0001).
Cross AJ, Greetham HL, Pollock JR, et al. Environ Mol Mutagen, 2006. PMID 16304669
2006 / Double-blind, placebo-controlled trial
A double-blind, placebo-controlled study in healthy humans evaluated the urinary excretion of the carcinogen N-nitrososarcosine during creatine supplementation. Participants took a high dose of creatine (20 g/d) for one week followed by a low dose (5 g/d) for 20 weeks. Oral creatine ingestion did not systematically elevate urinary excretion of N-nitrososarcosine.
Derave W, Vanden Eede E, Hespel P, et al. Nutrition, 2006. PMID 16413752
2006 / Randomized controlled trial
A randomized double-blind trial tested daily administration of 600 mg green tea catechins versus placebo in 60 men with high-grade prostate intraepithelial neoplasia over 1 year. One tumor was diagnosed among 30 men receiving catechins (approximately 3% incidence) compared with 9 cancers among 30 men receiving placebo (30% incidence). International Prostate Symptom Scores also improved significantly in treated men with coexistent benign prostatic hyperplasia.
Bettuzzi S, Brausi M, Rizzi F, et al. Cancer Res, 2006. PMID 16424063
2006 / Randomized crossover trial
In a randomized crossover trial, human volunteers consumed high red meat (420 g), vegetarian, and high red meat plus high-fiber diets for 15 days in a controlled volunteer suite. In 21 volunteers, endogenous formation of apparent total N-nitrosocompounds (ATNC) in feces significantly increased on the red meat diet compared with the vegetarian diet (P < 0.0001). Colonic exfoliated cells showed a significantly higher percentage staining positive for O(6)-carboxymethyl guanine (O(6)CMG) adducts on the high red meat diet (P < 0.001), with intermediate levels in 13 volunteers on the high-fiber, high red meat diet. Fecal ATNC correlated positively with the percentage of O(6)CMG-positive cells (r(2) = 0.56, P = 0.011).
Lewin MH, Bailey N, Bandaletova T, et al. Cancer Res, 2006. PMID 16452248
2006 / Intervention feeding experiment and cross-sectional comparison
Researchers determined the salicylate content of commonly used spices, Indian cooked dishes, and blood and urine samples taken after ingestion of a test meal, while also measuring serum salicylic acid concentrations in villagers from southern India compared with typical European values. Salicylic acid was detected in all spices (up to 1.5 wt %) and cooked dishes. Blood and urine salicylate content increased following meal consumption, indicating bioavailability. Additionally, serum salicylic acid levels in rural Indians were significantly higher, with a median almost 3-fold higher than values previously measured in Western vegetarians.
Paterson JR, Srivastava R, Baxter GJ, et al. J Agric Food Chem, 2006. PMID 16608205
2006 / Phase II clinical trial
A phase II clinical trial evaluated daily intake of eight ounces of pomegranate juice in men with rising prostate-specific antigen following prostate cancer surgery or radiation. Treatment significantly increased average prostate-specific antigen doubling time from 15 months at baseline to 54 months posttreatment (p < 0.001). Patient serum also displayed decreased prostate cancer cell proliferation, increased apoptosis, and reduced lipid oxidation markers in laboratory assays.
Pantuck AJ, Leppert JT, Zomorodian N, et al. Clin Cancer Res, 2006. PMID 16818701
2006 / Before-and-after trial
A 6-month pre-post clinical trial examined a plant-based diet combined with stress management among 14 individuals with recurrent prostate cancer. The rate of prostate-specific antigen (PSA) rise was significantly lower during the intervention than prestudy (P < .01). Among 10 evaluable patients, four experienced absolute decreases in PSA levels, and nine had reduced rates of PSA rise, with median PSA doubling time lengthening from 11.9 months prestudy to 112.3 months during the study.
Saxe GA, Major JM, Nguyen JY, et al. Integr Cancer Ther, 2006. PMID 16880425
2006 / Before-and-after trial
In a 6-month pre-post pilot trial, recurrent prostate cancer patients adopted a plant-based diet with stress management. Median daily whole grain intake was 1.7 servings at baseline, 6.9 at 3 months, and 5.0 at 6 months; vegetable intake was 2.8, 5.0, and 4.8 servings, respectively. The rate of PSA rise decreased from the prestudy period (0.059) to 0-3 months (-0.002, P < .01), inversely tracking changes in plant-food consumption.
Nguyen JY, Major JM, Knott CJ, et al. Integr Cancer Ther, 2006. PMID 16880426
2006 / Intervention study
Overweight/obese postmenopausal women followed a low-fat (10-15% kcal), high-fiber (30-40 g per 1,000 kcal/day) diet and attended daily exercise classes for 2 weeks. Serum estradiol decreased in women on hormone treatment (n = 28) and those not on hormone treatment (n = 10), while serum insulin and IGF-I significantly decreased and IGF binding protein-1 increased across all women. Using subjects' serum in vitro, growth was reduced by 6.6% in MCF-7 cells, 9.9% in ZR-75-1 cells, and 18.5% in T-47D cells, while apoptosis increased by 20% in ZR-75-1, 23% in MCF-7, and 30% in T-47D cells (n = 12).
Barnard RJ, Gonzalez JH, Liva ME, et al. Nutr Cancer, 2006. PMID 16965238
2006 / Dietary intervention trial
Researchers examined the effect of a low-fat, high-carbohydrate (LFHC) dietary intervention on time to menopause in 2,611 premenopausal women with extensive mammographic density followed for an average of 7 years. The LFHC intervention did not affect the time to natural menopause overall (P = 0.72 for log-rank test; n = 699 events). An interaction between study group and baseline BMI was observed (P = 0.01), showing earlier menopause in the intervention group when BMI was low, and later menopause associated with higher BMI only in the intervention group. Greater parity, weight, and education were associated with later menopause, whereas older age at first birth and baseline smoking were associated with earlier menopause.
Martin LJ, Greenberg CV, Kriukov V, et al. Am J Clin Nutr, 2006. PMID 17023721
2006 / Randomized crossover trial (plus rat studies)
Researchers evaluated urinary 8-iso-PGF(2)alpha and DHN-MA across two rat studies and a randomized crossover human trial testing four diets (60 g/d red meat baseline, 120 g/d red meat, baseline with heme iron, and baseline with non-heme iron). In humans, the heme-supplemented diet led to a 2-fold increase in urinary DHN-MA (P < 0.001), while 8-iso-PGF(2)alpha did not increase. In rats, high-heme diets dramatically increased DHN-MA in parallel with preneoplastic lesions (P < 0.0001) and moderately increased 8-iso-PGF(2)alpha (P < 0.0001).
Pierre F, Peiro G, Taché S, et al. Cancer Epidemiol Biomarkers Prev, 2006. PMID 17119057
2006 / Randomized controlled trial
A randomized prospective trial assigned 2,437 women with resected early-stage breast cancer to a dietary fat-reduction intervention (n = 975) or control (n = 1,462). After a median follow-up of 60 months, fat intake was lower in the intervention group (33.3 vs. 51.3 g/day at 12 months; P < .001), alongside a 6-pound lower mean body weight (P = .005). Relapse events occurred in 9.8% of the intervention group and 12.4% of controls, corresponding to a hazard ratio of 0.76 (95% CI = 0.60 to 0.98; P = .077 for stratified log rank, P = .034 for adjusted Cox model).
Chlebowski RT, Blackburn GL, Thomson CA, et al. J Natl Cancer Inst, 2006. PMID 17179478
2006 / Randomized controlled trial
In the MeDiet Project, 115 healthy postmenopausal women were randomized to either an intervention group following a traditional, restricted Mediterranean diet (n = 58) or a control group continuing their regular diet (n = 57) for 6 months. Women in the intervention group shifted from prevalent intake of animal fat and proteins to vegetable fat and proteins. After 6 months, women in the intervention group showed a significant decrease of over 40% in total urinary estrogen levels (P < 0.02), primarily driven by marked decreases in hydroxy- and keto-derivatives of estradiol or estrone, while control women showed no major change.
Carruba G, Granata OM, Pala V, et al. Nutr Cancer, 2006. PMID 17474873
2005 / Phase I clinical trial
A phase I dose-escalation trial evaluated oral green tea extract in 17 patients with advanced lung cancer. The maximum tolerated dose was established at 3 g/m2 per day, with dose-limiting toxicities including nausea, diarrhea, and hypertension. No objective tumor responses occurred, though seven participants maintained stable disease for 4 to 16 weeks before progressing.
Laurie SA, Miller VA, Grant SC, et al. Cancer Chemother Pharmacol, 2005. PMID 15309507
2005 / Double-blind, randomized, placebo-controlled crossover trial
In a double-blind, randomized, placebo-controlled crossover trial, 64 postmenopausal women with a history of breast cancer took 114 mg of isolated isoflavonoids or placebo daily for 3 months, separated by a 2-month washout period. Isolated isoflavones did not relieve vaginal dryness. Vaginal maturation index values remained unchanged during isoflavone treatment but decreased during placebo. No changes were observed in any endometrial variables, including thickness, histology, estrogen and progesterone receptors, or Ki-67 expression.
Nikander E, Rutanen EM, Nieminen P, et al. Fertil Steril, 2005. PMID 15652899
2005 / Prospective clinical trial
Nineteen patients with hormone refractory prostate cancer received 250 mg green tea extract capsules twice daily in a prospective clinical trial. Of the 15 participants who finished at least 2 months of treatment, 9 showed progressive disease within 2 months. The remaining 6 individuals developed disease progression after an additional 1 to 4 months of therapy, demonstrating minimal clinical efficacy.
Choan E, Segal R, Jonker D, et al. Urol Oncol, 2005. PMID 15869995